Credentialing

 

Radiation Therapy Oncology Group (RTOG)

Activated protocol list Closed protocol list
 
0022 - Phase I/II Study of Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer - CLOSED
0116 - A Two-part Phase I/II Study of Extended field External Irradiation and Intracavitary Brachytherapy Combined with Chemotherapy (weekly Cisplatin-arm 1) and Amifostine (weekly Cisplatin and Amifostine-arm 2) in Carcinoma of the Cervix with Positive Para-aortic or High Common Iliac lymph Nodes - CLOSED
0117 - A Phase I/II Dose Intensification Study using Three Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients with Inoperable, non-small Cell Lung Cancer.- CLOSED
0126 - A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer - CLOSED
0225 - A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) +/- Chemotherapy for Nasopharyngeal Cancer - CLOSED
0232 - A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy alone for Selected Patients with Intermediate Risk Prostatic Carcinoma -- CLOSED
0234 - A Phase II Randomized Trial of Surgery Followed by Chemoradiotherapy plus C225 (Cetuximab) for Advanced Squamous Cell Carcinoma of the Head and Neck - CLOSED
0236 - A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer. --CLOSED
0321 - Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate --CLOSED
0413 - A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with State 0,I, or II Breast Cancer ---Closed (4/16/2013)
0415 - A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-risk Prostate Cancer --CLOSED
0417 - A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma --CLOSED
0418 - A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis +/- Chemotherapy for Post-operative Patients with either Endometrial or Cervical Carcinoma --CLOSED
0421 - A Phase III Trial for Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-irradiation and Chemotherapy versus Chemotherapy alone.---Closed
0435 - A Randomized, Phase III,Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin for the Reduction of Oral Mucositis in Patients with Locally Advanced Head and Neck Cancer Receiving Radiation Therapy with Concurrent Chemotherapy. --CLOSED
0438 - A Phase I Trial of Highly Conformal Radiation Therapy for Patients with Liver Metastases. --CLOSED
0521 - A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT vs AS and 3DCRT/IMRT Followed by Chemotherapy With Docetaxel and Prednisone for Localized, High-Risk Prostate Cancer.---Closed(8/21/2009)
0522 - A Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225)[Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas. --CLOSED
0529 - A Phase II Evaluation of Dose-Painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal---Closed
0539 - Phase II Trial of Observation For Low-Risk Meningiomas and of Radiotherapy for Intermediate - and High-Risk Meningiomas---Closed
0615 - A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer ---Closed(2/5/2009)
0617 - A Randomized Phase III Comparison of Standard-dose (60 Gy) versus High-dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/paclitaxel in Patients with Stage IIIA/IIIB Non-small Cell Lung Cancer---CLOSED(11/22/2011)
0618 - A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer --CLOSED(5/17/2010)
0619 - A Randomized Phase II Trial of Chemoradiotherapy Versus Chmoradiotherapy and Vandetanib For High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck. --CLOSED(5/3/2010)
0621 - Adjuvant 3DCRT/IMRT in Combination with Androgen Suppression and Docetaxel for High Risk Prostate Cancer Patients Post-Prostatectomy: a Phase II trial - CLOSED
0623 - A Phase II trial of combined modality therapy with growth factor support for patients with limited stage small cell lung cancer. --CLOSED(4/6/2009)
0630 - A Phase II Trial of Image Guided Preoperative Radiotherapy for Primary Soft Tissue Sarcomas of the Extremities. --CLOSED(9/23/2010)
0822 - A Phase II Evaluation of Preoperative Chemoradiotherapy utilizing Intensity Modulated Radiation Therapy (IMRT) in combination with Capecitabine and Oxaliplatin for patients with locally Advanced Rectal Cancer - CLOSED
0825 - Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma - CLOSED (5/11/2011)
0831 - A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer - CLOSED(2/16/2012)
0837 - Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation And Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation And Adjuvant Temozolomide Plus Placebo In Patients With Newly Diagnosed Glioblastoma ---Closed (5/9/2012)
0915 - A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules For Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer ---Closed(3/22/2011)
0921 - A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) With Concurrent Cisplatin and Bevacizumab Followed By Carboplatin and Paclitaxel For Patients with Endometrial Cancer ---Closed(12/12/2011)
0933 - A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases ---Closed 11/7/2012
1021 - A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)---CLOSED(5/15/2013)